Table 1 Industry Outlook: Incidence, Mortality, and Prevalence of Lung Cancer in Japan, 2022
Table 2 Industry Outlook: Number of Lung Cancer Surgery Cases in Japan 2020, By Stage
Table 3 PESTLE Impact Analysis: Political Factors
Table 4 PESTLE Impact Analysis: ECONOMICAL FACTORS
Table 5 PESTLE Impact Analysis: Social Factors
Table 6 PESTLE Impact Analysis: Technological Factors
Table 7 PESTLE Impact Analysis: LEGAL FACTORS
Table 8 Market Trend: AI Applications in Lung Cancer Screening
Table 9 Market Opportunity: First-in-human Phase I/II Clinical Trials Of EGFR Targeted Agents For NSCLC
Table 10 Market Opportunity: First-in-human Phase I/II Clinical Trials Of EGFR Targeted Agents For NSCLC
Table 11 Cost Analysis: Cost of Illness Price Analysis
Table 12 Competitive Dashboard: Japan Lung Cancer Market Competitors Mapping & Benchmarking
Table 13 Japan Lung Cancer Market Size (US$ Mn), By Diagnostics & Therapy, 2019-2032
Table 14 Japan Lung Cancer Market Size (US$ Mn), By Cancer Type, 2019-2032
Table 15 Japan Lung Cancer Market Size (US$ Mn), By End User, 2019-2032
Table 16 Accuray Incorporated:  Recent Developments
Table 17 Accuray Incorporated: Products
Table 18 Accuray Incorporated: Financial Analysis
Table 19 Intuitive Surgical, Inc.: Recent Developments
Table 20 Intuitive Surgical, Inc.: Products
Table 21 Intuitive Surgical, Inc.: Financial Analysis
Table 22 Karl Storz SE & Co. KG: Recent Developments
Table 23 Karl Storz SE & Co. KG: Products
Table 24 Medtronic plc: Recent Developments
Table 25 Medtronic plc: Products
Table 26 Medtronic plc: Financial Analysis
Table 27 Olympus Corporation: Products
Table 28 Olympus Corporation: Financial Analysis
Table 29 Teleflex Incorporated: Recent Developments
Table 30 Teleflex Incorporated: Products
Table 31 Teleflex Incorporated: Financial Analysis
Table 32 Other Prominent Players

Figure 1 Executive Summary: Japan Lung Cancer Market Revenue (US$ Mn), 2019-2032
Figure 2 Industry Outlook: Trends In The Number Of Lung Cancer Patients In Japan
Figure 3 Industry Outlook: Number of Lung Cancer Surgery Cases in Japan 2020, By Gender
Figure 4 Industry Outlook: Strategies and Treatment Choices for Lung Cancer Patient
Figure 5 Market Driver: New Lung Cancer Cases in Japan, 2022
Figure 6 Market Driver: New Lung Cancer Cases in Japan, 2022
Figure 7 Market Driver: Population ages 65 and above (% of total population)
Figure 8 Market Driver: Population by Age Group, (In Thousand)
Figure 9 Covid -19 Impact & Recovery: Japan Lung Cancer Market, Covid-19 Impact & Recovery, By Y-o-Y (%), 2019-2032 
Figure 10 Competitive Dashboard: Market Share Analysis by Company, Based on Revenue of Equipment Market (US$ Mn)  (2019)
Figure 11 Japan Lung Cancer Market, By Diagnostics & Therapy, CAGR (%), 2024-2032
Figure 12 Japan Lung Cancer Market Share (%), By Diagnostics & Therapy, 2019
Figure 13 Japan Lung Cancer Market Share (%), By Diagnostics & Therapy, 2032
Figure 14 Japan Lung Cancer Market, By Cancer Type, CAGR (%), 2024-2032
Figure 15 Japan Lung Cancer Market Share (%), By Cancer Type, 2019
Figure 16 Japan Lung Cancer Market Share (%), By Cancer Type, 2032
Figure 17 Japan Lung Cancer Market, By End User, CAGR (%), 2024-2032
Figure 18 Japan Lung Cancer Market Share (%), By End User, 2019
Figure 19 Japan Lung Cancer Market Share (%), By End User, 2032
Figure 20 Accuray Incorporated: Business Revenue Segmentation, 2019
Figure 21 Accuray Incorporated: Geographical Revenue Segmentation, 2019
Figure 22 Intuitive Surgical, Inc.: Business Revenue Segmentation, 2019
Figure 23 Intuitive Surgical, Inc.: Geographical Revenue Segmentation, 2019
Figure 24 Medtronic plc: Business Revenue Segmentation, 2019
Figure 25 Medtronic plc: Geographical Revenue Segmentation, 2019
Figure 26 Olympus Corporation: Business Revenue Segmentation, 2019
Figure 27 Geographical Revenue Segmentation, 2019: Geographical Revenue Segmentation, 2019
Figure 28 Teleflex Incorporated: Business Revenue Segmentation, 2019
Figure 29 Teleflex Incorporated: Geographical Revenue Segmentation, 2019